We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$197B
AUM Growth
-$10.1B
Cap. Flow
-$12.7B
Cap. Flow %
-6.46%
Top 10 Hldgs %
21.27%
Holding
10,783
New
2,442
Increased
3,513
Reduced
3,383
Closed
1,274

Sector Composition

Rank Sector Weight
1 Technology 1.75%
2 Consumer Discretionary 1.45%
3 Healthcare 1.23%
4 Financials 1.18%
5 Energy 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GYRE icon
9426
Gyre Therapeutics
GYRE
$705M
$15K ﹤0.01%
+209
New +$18.8K
RBCN
9427
DELISTED
Rubicon Technology, Inc.
RBCN
$15K ﹤0.01%
+2,474
New +$13.8K
RHE
9428
PUT
DELISTED
Regional Health Properties, Inc.
RHE
$15K ﹤0.01%
883
-459
-34% -$9.34K
XXII
9429
PUT
22nd Century Group
XXII
$2.42M
0
PLUG icon
9430
CALL
Plug Power
PLUG
$3.03B
$13K ﹤0.01%
10,500
-22,600
-68% -$33.2K
SINT icon
9431
SiNtx Technologies
SINT
$10.5M
0
CYTO
9432
PUT
DELISTED
Altamira Therapeutics Ltd
CYTO
0
TPLM
9433
DELISTED
Triangle Petroleum Corporation
TPLM
$13K ﹤0.01%
+54,974
New +$15K
GFA
9434
DELISTED
Gafisa S.A.
GFA
$13K ﹤0.01%
858
-843
-50% -$15.7K
XXII
9435
CALL
22nd Century Group
XXII
$2.42M
0
BETS
9436
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
SNOAW
9437
DELISTED
Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
$12K ﹤0.01%
+32,517
New +$11.9K
UQM
9438
DELISTED
UQM Technologies, Inc.
UQM
$12K ﹤0.01%
27,678
-14,728
-35% -$7.61K
NUWE icon
9439
Nuwellis
NUWE
$3.21M
0
ENSV
9440
DELISTED
Enservco Corp.
ENSV
$11K ﹤0.01%
+1,293
New +$10.8K
IMNP
9441
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$11K ﹤0.01%
2,974
-1,367
-31% -$5.62K
STLY
9442
DELISTED
Stanley Furniture Co Inc
STLY
$11K ﹤0.01%
+12,131
New +$14.9K
XPL icon
9443
Solitario Resources
XPL
$76M
$10K ﹤0.01%
15,510
-4,451
-22% -$2.94K
XTIA icon
9444
XTI Aerospace
XTIA
$53.5M
0
RNVAZ
9445
DELISTED
Rennova Health, Inc. Warrant
RNVAZ
$10K ﹤0.01%
+432,015
New +$16.9K
RGSE
9446
DELISTED
Real Goods Solar, Inc. Class A
RGSE
$10K ﹤0.01%
+1,425
New +$45.3K
GMAN
9447
DELISTED
Gordmans Stores, Inc.
GMAN
$10K ﹤0.01%
+14,941
New +$11.5K
OGEN icon
9448
Oragenics
OGEN
$2.39M
$9K ﹤0.01%
+1
New +$9.28K
GAZ
9449
DELISTED
iPath Bloomberg Natural Gas Subindex Total Return ETN due October 22, 2037
GAZ
$9K ﹤0.01%
13,938
-33,660
-71% -$19.4K
ANTH
9450
PUT
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$8K ﹤0.01%
1,525
-5,125
-77% -$88.7K

Similar funds

Jeff Yass's Q4 2016 Portfolio in Review

As of Q4 2016, Jeff Yass held 10,783 positions worth $197B, down 4.9% from $207B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Jeff Yass withdrew a net $12.7B in Q4 2016, closing 1,274 positions and reducing 3,383 holdings. Its most notable exit was Synchrony, an estimated $104M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Jeff Yass opened a new position in Basis Energy Services, Inc. worth $59.7M.

  • Jeff Yass's largest Q4 2016 buy was Basis Energy Services, Inc.: 1,689,160 shares worth $59.7M.
  • Jeff Yass added most to Amazon in Q4 2016, an estimated $685M increase.
  • Jeff Yass's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $3.97B.
  • Jeff Yass fully exited Synchrony in Q4 2016, selling an estimated $104M.
  • Jeff Yass's ten largest holdings make up 21% of its $197B portfolio in Q4 2016.
  • Jeff Yass opened 2,442 new positions and closed 1,274 in Q4 2016.
  • Jeff Yass's portfolio value fell 4.9% quarter-over-quarter to $197B.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.